Perspectives
CME Article: Psychiatric Aspects of Sickle Cell Disease
Abstract
There is little specific research on common psychiatric conditions in sickle cell disease (SCD). Conditions involving chronic pain are known to co-occur with depression and anxiety to a high degree, and greater chronicity and severity of pain tend to be linked more closely with both depressive symptoms and the diagnosis of major depressive disorder.1–7 Causal relations between chronic pain and psychiatric comorbidity are difficult to elucidate for a number of reasons, but the current state of evidence suggests a bidirectional relation.8This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004;111:77-83.
2. Geisser ME, Robinson ME, Keefe FJ, et al. Catastrophizing, depression and the sensory, affective and evaluative aspects of chronic pain. Pain 1994;59:79-83.
3. Bair MJ, Wu J, Damush TM, et al. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 2008;70:890-897.
4. Srinivasan K, Joseph W. A study of lifetime prevalence of anxiety and depressive disorders in patients presenting with chest pain to emergency medicine. Gen Hosp Psychiatry 2004;26:470-474.
5. Patten SB, Williams JV, Lavorato DH, et al. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry 2008;30:407-413.
6. Asghari A, Julaeiha S, Godarsi M. Disability and depression in patients with chronic pain: pain or pain-related beliefs? Arch Iran Med 2008;11:263-269.
7. Blozik E, Laptinskaya D, Herrmann-Lingen C, et al. Depression and anxiety as major determinants of neck pain: a cross-sectional study in general practice. BMC Musculoskelet Disord 2009;10:13.
8. Kroenke K, Wu J, Bair MJ, et al. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 2011;12:964-973.
9. Edwards RR, Smith MT, Klick B, et al. Symptoms of depression and anxiety as unique predictors of pain-related outcomes following burn injury. Ann Behav Med 2007;34:313-322.
10. Fishbain DA, Cole B, Lewis JE, et al. Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review. Pain Med 2014;15:1522-1539.
11. Bair MJ, Robinson RL, Eckert GJ, et al. Impact of pain on depression treatment response in primary care. Psychosom Med 2004;66:17-22.
12. Kroenke K, Bair MJ, Damush TM, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009;301:2099-2110.
13. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003;290:2428-2429.
14. Ushinsky A, Reinhardt LE, Simmons AN, et al. Further evidence of emotional allodynia in unmedicated young adults with major depressive disorder. PLoS One 2013;8:e80507.
15. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005;52:1577-1584.
16. Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol 2015;50:1609-1640.
17. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16:355-363.
18. Hø J, Sjø P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007;11:490-518.
19. Hø J, Nielsen PR, Guldstrand SK, et al. Classification and identification of opioid addiction in chronic pain patients. Eur J Pain 2010;14:1014-1020.
20. Sullivan MD, Von Korff M, Banta-Green C, et al. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain 2010;149:345-353.
21. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain 2007;130:144-156.
22. Jensen MK, Thomsen AB, Hojsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur J Pain 2006;10:423-433.
23. Choiniè M, Dion D, Peng P, et al. The Canadian STOP-PAIN project-part 1: who are the patients on the waitlists of multidisciplinary pain treatment facilities? Can J Anaesth 2010;57:539-548.
24. Goesling J, Henry MJ, Moser SE, et al. Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain 2015;16:844-851.
25. Citero Vde A, Levenson JL, McClish DK, et al. The role of catastrophizing in sickle cell disease-the PiSCES project. Pain 2007;133:39-46.
26. Edwards RR, Smith MT, Stonerock G, et al. Pain-related catastrophizing in healthy women is associated with greater temporal summation of and reduced habituation to thermal pain. Clin J Pain 2006;22:730-737.
27. Granot M, Ferber SG. The roles of pain catastrophizing and anxiety in the prediction of postoperative pain intensity: a prospective study. Clin J Pain 2005;21:439-445.
28. Thorn BE, Pence LB, Ward LC, et al. A randomized clinical trial of targeted cognitive behavioral treatment to reduce catastrophizing in chronic headache sufferers. J Pain 2007;8:938-949.
29. Mackin RS, Insel P, Truran D, et al. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology 2014;82:835-841.
30. Strouse JJ, Jordan LC, Lanzkron S, et al. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol 2009;84:548-552.
31. Strouse JJ, Lanzkron S, Urrutia V. The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol 2011;4:597-606.
32. Vichinsky EP, Neumayr LD, Gold JI, et al. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010;303:1823-1831.
33. Wison Schaeffer JJ, Gil KM, Burchinal M, et al. Depression, disease severity, and sickle cell disease. J Behav Med 1999;22:115-126.
34. Grant MM, Gil KM, Floyd MY, et al. Depression and functioning in relation to health care use in sickle cell disease. Ann Behav Med 2000;22:149-157.
35. Smith WR, McClish DK, Dahman BA, et al. Daily home opioid use in adults with sickle cell disease: the PiSCES project. J Opioid Manag 2015;11:243-253.
36. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med 2008;70:192-196.
37. Laurence B, George D, Woods D. Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease. J Natl Med Assoc 2006;98:365-369.
38. Belgrave FZ, Molock SD. The role of depression in hospital admissions and emergency treatment of patients with sickle cell disease. J Natl Med Assoc 1991;83:777-781.
39. Hoff AL, Palermo TM, Schluchter M, et al. Longitudinal relationships of depressive symptoms to pain intensity and functional disability among children with disease-related pain. J Pediatr Psychol 2006;31:1046-1056.
40. Carroll PC, Haywood C Jr, Hoot MR, et al. A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients. Clin J Pain 2013;29:317-323.
41. Haywood C Jr, Lanzkron S, Hughes MT, et al. A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment. J Gen Intern Med 2011;26:518-523.
42. Armstrong FD, Pegelow CH, Gonzalez JC, et al. Impact of children’ sickle cell history on nurse and physician ratings of pain and medication decisions. J Pediatr Psychol 1992;17:651-664.
43. Waldrop RD, Mandry C. Health professional perceptions of opioid dependence among patients with pain. Am J Emerg Med 1995;13:529-531.
44. Elander J, Marczewska M, Amos R, et al. Factors affecting hospital staff judgments about sickle cell disease pain. J Behav Med 2006;29:203-214.
45. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-130.
46. Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-146.
47. Evans S, Fishman B, Spielman L, et al. Randomized trial of cognitive behavior therapy versus supportive psychotherapy for HIV-related peripheral neuropathic pain. Psychosomatics 2003;44:44-50.
48. Chou R, Huffman LH, American Pain Society American College of Physicians. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:492-504.
49. Gil KM, Carson JW, Sedway JA, et al. Follow-up of coping skills training in adults with sickle cell disease: analysis of daily pain and coping practice diaries. Health Psychol 2000;19:85-90.
50. Gil KM, Wilson JJ, Edens JL, et al. Effects of cognitive coping skills training on coping strategies and experimental pain sensitivity in African American adults with sickle cell disease. Health Psychol 1996;15:3-10.
51. Thomas VJ, Gruen R, Shu S. Cognitive-behavioural therapy for the management of sickle cell disease pain: identification and assessment of costs. Ethn Health 2001;6:59-67.
52. Anie KA, Green J. Psychological therapies for sickle cell disease and pain. Cochrane Database Syst Rev 2002;2:CD001916.
53. Palermo TM, Kiska R. Subjective sleep disturbances in adolescents with chronic pain: relationship to daily functioning and quality of life. J Pain 2005;6:201-207.
54. Edwards RR, Almeida DM, Klick B, et al. Duration of sleep contributes to next-day pain report in the general population. Pain 2008;137:202-207.
55. Edwards RR, Grace E, Peterson S, et al. Sleep continuity and architecture: associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur J Pain 2009;13:1043-1047.
56. Campbell CM, Buenaver LF, Finan P, et al. Sleep, pain catastrophizing, and central sensitization in knee osteoarthritis patients with and without insomnia. Arthritis Care Res (Hoboken) 2015;67:1387-1396.
57. Campbell CM, Moscou-Jackson G, Carroll CP, et al. An evaluation of central sensitization in patients with sickle cell disease. J Pain 2016;17:617-627.
